Drugs / KMY
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07314541 | Dec 2025 → Nov 2026 expected | — | Lei Yunshang Group | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KMY | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07314541 ↗ |
| Route | Oral | “single oral doses of KMY Tablets” NCT07314541 ↗ |